• 제목/요약/키워드: Human placenta

검색결과 92건 처리시간 0.021초

자하거(紫河車)가 자궁근종세포(子宮筋腫細胞)의 성장억제(成長抑制)와 세포자멸사(細胞自滅死)에 미치는 영향(影響) (Effects of Hominis Placenta on the Growth of Human Uterine Myoma Cells and Cell Apoptosis)

  • 위효선;이진무;이창훈;조정훈;장준복;이경섭
    • 대한한방부인과학회지
    • /
    • 제21권2호
    • /
    • pp.38-48
    • /
    • 2008
  • Purpose: This study was conducted to investigate the effects of Hominis Placenta (紫河車) on the growth of human uterine myoma cells and cell apoptosis. Methods: Human uterine leiomyoma cells were cultured and treated with Hominis Placenta extract for 48 hours. Cell proliferation and activity was analyzed by MTT assay. We analyzed the cell cycle of human uterine myoma cells treated Hominis Placenta extract by FACS. Expression of proteins related to cell apoptosis (Bax, Bcl-2), cyclin-D1 and VEGF were evaluated by Western blotting method. Results: The human uterine myoma cells treated by Hominis Placenta extract didn't proliferate below the concentration of $10mg/m{\ell}$. And there was no remarkable difference on cell cycle analysis below the concentration of $10mg/m{\ell}$. The expression of Bax was decreased and the expression of Bcl-2 was increased after the treatment of Hominis Placenta extract. But the expressions of cyclin-D1 and VEGF were increased after the treatment of Hominis Placenta extract. Conclusion: This study suggests that Hominis Placenta induce uterine myoma cell apoptosis and have effect on the myoma cell proliferation in the concentraion below $10mg/m{\ell}$.

  • PDF

자하거약침의 부인과 질환 임상 연구에 대한 고찰 (The Review on Trend of Clinical Studies of Hominis Placenta Pharmacopuncture on Obstetrics & Gynecology Diseases)

  • 최수지;김동일
    • 대한한방부인과학회지
    • /
    • 제32권1호
    • /
    • pp.15-25
    • /
    • 2019
  • Objectives: The aim of this study is to review clinical studies of Hominis Placenta Pharmacopuncutre on Obstetrics & Gynecology diseases. Methods: Key words "Jahageo Yakchim", "Hominis Placenta Pharmacopuncture", "Human Placenta Pharmacopuncture", "Hominis Placenta Pharmacoacupuncutre" were searched on 6 database systems (DBpia, KISS, KTKP, NDSL, Pubmed, CENTRAL) on August 31th 2018. Results: 1 case reports and 4 controlled studies were collected in accordance with the selection and exclusion criteria. The study design, study results and method of intervention were analyzed. Conclusions: This review shows the necessity of large-scale well designed clinical studies of Hominis Placenta Pharmacopuncture on Obstetrics & Gynecology diseases to evaluate the efficacy and safety.

미세수술 술기 습득을 위한 태반의 사용 (Use of Human Placentas for Practice of Microvascular Surgery)

  • 강민구;윤상엽;장학
    • Archives of Reconstructive Microsurgery
    • /
    • 제16권2호
    • /
    • pp.53-56
    • /
    • 2007
  • Purpose: Microsurgical exercise has been performed with rat femoral vessels. But, it needs animal laboratory, anesthesia and its keeping facilities. Materials and Methods: Ten human placentas were studied for suitability in a microvascular exercise. The size and useful length of vessels were measured, and various microvascular anastomoses were performed. Result: The human placenta has many vessels traversing its fetal surface. A variety of sizes are available down to vessels of diameter 1 mm and up to vessels of diameter 6.5 mm (1.0

  • PDF

태반추출물이 인간 연골세포의 증식과 분화에 미치는 영향 (The Effect of Placenta Extract on Proliferation and Differentiation of Human Chondrocytes)

  • 허준;서만수;박세정;임영국;신준호;정호윤;조병채;박재우
    • Archives of Plastic Surgery
    • /
    • 제33권5호
    • /
    • pp.616-620
    • /
    • 2006
  • Purpose: The isolated human chondrocytes for cartilage reconstruction and transplantation presents a major problem as these cells would change biologically in vitro. For more effective applications of these cells in the clinical field, it is necessary to get a large amount of cells in a short period without affecting their function and phenotype. Methods: This study reports the effects of placenta extract on chondrocytes in vitro. We initiated this study on the basis of the hypothesis that placenta extract can influence both the proliferation of chondrocytes and their biologic functions(for example, to express cell specific gene or to produce their own extracellular matrix). Chondrocytes in monolayer culture with or without placenta extract were collected and analyzed by MTT assay, ECM assay, and RT-PCR. Results: Placenta extract stimulated the proliferation of chondrocytes in monolayer culture. The phenotype of chondrocytes was well maintained during the expansion in monolayers. Chondrocytes expanded in the presence of placenta extract produced ECM, glycosaminoglycan, abundantly. Compared to chondrocyte expanded in culture medium only, chondrocytes expanded with placenta extract demonstrated higher COL2A1 expression that was biochemically comparable to primary chondrocytes. This study provides an evidence that placenta extract is helpful to expand chondrocytes during tissue cultivation, to maintain their differentiated phenotype and to promote their function. Conclusion: These results suggest that placenta extract during cultivation play an important role in controlling cell behaviors. Furthermore, these results provide a biologic basis for cartilage tissue engineering.

임산부의 혈중 엽산과 호모시스틴 수준이 태반세포의 DNA 메틸화에 미치는 영향 (Folate and Homocysteine Levels during Pregnancy affect DNA Methylation in Human Placenta)

  • 박보현;김영주;이화영;하은희;민정원;박종순;박혜숙
    • Journal of Preventive Medicine and Public Health
    • /
    • 제38권4호
    • /
    • pp.437-442
    • /
    • 2005
  • Objectives : DNA methylation is one of the best characterized epigenetic mechanisms that play a regulatory role in genome programming and imprinting during embryogenesis. In this present study, we investigated the association between DNA methylation in the human placenta and the maternal folate and homocysteine concentrations on the Methylenetetrahydrofolatereductase (MTHFR) genetic polymorphism during pregnancy. Methods : We investigated 107 pregnant women who visited Ewha Woman's University Hospital for prenatal care during their $24{\sim}28$ weeks-period of gestation. During the second trimester, we measured the serum homocysteine and folate concentrations . The MTHFR 677 genetic polymorphism was determine by performing PCR-RFLP assay. The expression of DNA methylation in the human placentas was estimated by using immunohistochemistry method. Results : Serum folate was negatively correlated with the serum homocysteine concentration for all the MTHFR genotypes. We found positive correlation between the folate concentrations and the DNA methylation in the human placenta (p<0.05). An increasing concentration of homocysteine was associated with reduced DNA methylation in the human placenta. The coefficient value was -2.03 (-3.77, -0.29) on the regression model (p<0.05). Conclusion : These findings suggest that the maternal folate and homocysteine levels along with the MTHFR 677 genetic polymorphism during pregnancy affect the DNA methylation in the human placenta.

임신초기 사람의 태반조직에서 GnRH-II mRNA와 Peptide의 발현 (Expression of the Second Isoform of Gonadotropin-Releasing Hormone (Chicken GnRH-II Type) in the First Trimester Human Placenta)

  • 천강우;홍성란;이형송;강인수
    • 한국발생생물학회지:발생과생식
    • /
    • 제5권1호
    • /
    • pp.81-88
    • /
    • 2001
  • GnRH는 10개의 아미노산으로 구성된 호르몬으로서 생식기능을 조절, 관장하는 중요한 역할을 담당하는 것으로 알려져 있다. 특히 임신 중에는 태반에서 hCG의 분비를 조절하는 중요한 역할을 한다. 최근 사람의 두 번째 GnRH 유전자가 발견되었으며 그 10개의 아미노산 서열은 닭에서 두 번째로 발견된 GnRH (chicken GnRH-II)와 동일한 것으로 확인되었다. 이제까지 사람에서의 두 번째 GnRH (GnRH-II)의 발현은 중뇌와 신장에서 보고된 바 있으며, 본 연구자들에 의해서 처음으로 사람의 자궁내막에서의 발현이 보고되었다 (Cheon et al., 2001). 이에 본 연구에서는 임신초기의 태반조직에서 GnRH-II의 mRNA와 Peptide가 발현되는가를 조사하였다. 본 연구결과를 통해 태반에서 발현되는 GnRH-II mRNA는 두 가지 형태라는 것이 확인되었으며, 특히 GAP 부위에 21개의 뉴클레오티드 결실을 갖는 작은 전사체는 조직 특이적인 alternative splicing 기작에 의하여 태반조직에서만 특이적으로 발현되는 것으로 확인되었다. 면역화학염색법을 이용하여 GnRH-II peptide의 발현을 조사한 결과, 세포영양막과 융합영양막의 세포질에서 모두 발현되는 것으로 확인되었으며, 특히 세포영양막에서 더 많은 양이 발현되었다. 이상의 결과는 임신초기 태반에서 기존의 GnRH (GnRH-I)이외에도 다른 아미노산 서열의 GnRH-II가 발현된다는 사실을 말해주며 이는 GnRH-II 역시 태반조직에서 임신의 유지 및 생식기능의 조절에 관여할 가능성을 시사한다 하겠다.

  • PDF

Expression of steroidogenic enzymes in human placenta according to the gestational age

  • SO‑HYE HONG;SEUNG CHUL KIM;MEE‑NA PARK;JEA SIC JEONG;SEUNG YUN YANG;YOUNG JOO LEE;OK‑NAM BAE;HOE‑SAENG YANG;SUNGBAEK SEO;KYU‑SUP LEE;BEUM‑SOO AN
    • Molecular Medicine Reports
    • /
    • 제19권5호
    • /
    • pp.3903-3911
    • /
    • 2019
  • Female sex steroid hormones, including estradiol (E2) and progesterone (P4), serve significant physiological roles in pregnancy. In particular, E2 and P4 influence placenta formation, maintain pregnancy and stimulate milk production. These hormones are produced by ovaries, adrenal glands and the placenta, of which the latter is a major endocrine organ during pregnancy. However, the mechanism of hormone production during pregnancy remains unclear. In the present study, the regulation of steroid hormones and steroidogenic enzymes was examined in human placenta according to gestational age. In human placental tissues, expression levels of steroidogenic enzymes were determined with reverse transcription-quantitative polymerase chain reaction and western blotting. The mRNA and protein expression of CYP17A1, HSD17B3 and CYP19A1, which are associated with the synthesis of dehydroepiandrosterone (DHEA) and E2, was elevated at different gestational ages in human placenta. In addition, to evaluate the correlation between serum and placental-produced hormones, steroid hormone levels, including pregnenolone (PG), DHEA, P4, testosterone (T) and E2, were examined in serum and placenta. Serum and placenta expression of DHEA and E2 increased with gestational age, whereas T and P4 were differently regulated in placenta and serum. To confirm the mechanism of steroidogenesis in vitro, placental BeWo cells were treated with E2 and P4, which are the most important hormones during pregnancy. The mRNA and protein expression of steroidogenic enzymes was significantly altered by E2 in vitro. These results demonstrated that concentration of steroid hormones was differently regulated by steroidogenic enzymes in the placenta depending on the type of the hormones, which may be critical to maintain pregnancy.

Placenta Transfer and Toxicokinetics of Valproic Acid in Pregnant Cynomolgus Monkeys

  • Jeong, Eun-Ju;Yu, Wook-Joon;Kim, Choong-Yong;Chung, Moon-Koo
    • Toxicological Research
    • /
    • 제26권4호
    • /
    • pp.275-283
    • /
    • 2010
  • Placenta transfer study in non-human primate (NHP) is one of the crucial components in the assessment of developmental toxicity because of the similarity between NHP and humans. To establish the method to determine placenta transfer in non-human primate, toxicokinetics of valproic acid (VPA), a drug used to treat epilepsy in pregnant women, were determined in pregnant cynomolgus monkeys. After mating, pregnancy-proven females were daily administered with VPA at dose levels of 0, 20, 60 and 180 mg/kg by oral route during the organogenesis period from gestation day (GD) 20 to 50. Concentrations of VPA and its metabolite, 4-ene-VPA, in maternal plasma on GDs 20 and 50, and concentrations of VPA and 4-ene-VPA in placenta, amniotic fluid and fetus on GD 50 were analyzed using LC/MS/MS. Following single oral administration of VPA to pregnant monkeys, concentrations of VPA and 4-ene-VPA were generally quantifiable in the plasma from all treatment groups up to 4-24 hours post-dose, demonstrating that VPA was absorbed and the monkeys were systemically exposed to VPA and 4-ene-VPA. After repeated administration of VPA to the monkeys, VPA was detected in amniotic fluid, placenta and fetus from all treatment groups, demonstrating that VPA was transferred via placenta and the fetus was exposed to VPA, and the exposures were increased with increasing dose. Concentrations of 4-ene-VPA in amniotic fluid and fetus were below the limit of quantification, but small amount of 4-ene-VPA was detected in placenta. In conclusion, pregnant monkeys were exposed to VPA and 4-ene-VPA after oral administration of VPA at dose levels of 20, 60 and 180 mg/kg during the organogenesis period. VPA was transferred via placenta and the fetus was exposed to VPA with dose-dependent exposure. The metabolite, 4-ene VPA, was not detected in both amniotic fluid and fetus, but small amount of 4-ene-VPA was detected in placenta. These results demonstrated that proper procedures to investigate placenta transfer in NHP, such as mating and diagnosis of pregnancy via examining gestational sac with ultrasonography, collection of amniotic fluid, placenta and fetus after Caesarean section followed by adequate bioanalysis and toxicokinetic analysis, were established in this study using cynomolugus monkeys.

태반성성선자극(胎盤性性腺刺戟)홀몬에 관(關)한 검토(檢討) (Studies on Placental Chorionic Gonadotropin)

  • 박완희
    • Journal of Nutrition and Health
    • /
    • 제8권1호
    • /
    • pp.65-69
    • /
    • 1975
  • Human chorionic gonadotropin hormone(H.C.G.) is secreted from the villus tissues of the placenta and excreted in lange amount into the urine. Its isolation is chiefly made from the urine of a pregnant woman. Recently, Matsushima attempted isolation of H.C.G. directly from the placenta itself. In order to prepare H.C.G. from human placenta, general method of extractiag and purifying proteins was applied. Its way was as follow: Crude H.C.G. was extracted from placenta with pH 9.0 and pH 5.0 aqua ammonia, and purified with pH 8.0 ammonia and 50% ethanol at pH 4.8. The purified H.C.G. showed two moving bands on the anode by paper electrophoresis. On the other hand, the H.C.G. from pregnancy urine (Standard. Pharm. Co.) showed same two bands but their moving ratio were different. The purified H.C.G. showed gonadotropin effect when it was injected young fomale rats 40r/cc per day for 5 days and weighted the increased ovary weight.

  • PDF

태반 및 제대에서의 특이적 세포구조물의 분리배양 (Isolation and Cultivation of Particular Cell Organism from Human Placenta and Umbilical Cord)

  • 손윤희;김소연;남경수;임종국
    • Korean Journal of Acupuncture
    • /
    • 제19권1호
    • /
    • pp.1-6
    • /
    • 2002
  • It was proposed that the substance of Kyungrak is a new anatomic-histological system in the living body and entirely different either from the nervous system or blood and lyphatic vessels. This system is covering the whole body, regulating and coordinating the biological processes that lie at the bottom of the vital activity. One of the substance of Kyungrak is acublast. The aim of this study was to isolate and culture the acublast from human placenta or blood of umbilical cord. It was found that particular cell organism isolate from placenta and cultured with RPMI 1640 contaning 10% FBS and hormones was grown for four weeks. Although this organism was different from blood cells morphologically, biochemical study of the organism is required to identify as the acublast.

  • PDF